Nanocarrier vaccines for SARS-CoV-2

The SARS-CoV-2 global pandemic has seen rapid spread, disease morbidities and death associated with substantive social, economic and societal impacts. Treatments rely on re-purposed antivirals and immune modulatory agents focusing on attenuating the acute respiratory distress syndrome. No curative t...

詳細記述

保存先:
書誌詳細
出版年:Adv Drug Deliv Rev
主要な著者: Machhi, Jatin, Shahjin, Farah, Das, Srijanee, Patel, Milankumar, Abdelmoaty, Mai Mohamed, Cohen, Jacob D., Singh, Preet Amol, Baldi, Ashish, Bajwa, Neha, Kumar, Raj, Vora, Lalit K., Patel, Tapan A., Oleynikov, Maxim D., Soni, Dhruvkumar, Yeapuri, Pravin, Mukadam, Insiya, Chakraborty, Rajashree, Saksena, Caroline G., Herskovitz, Jonathan, Hasan, Mahmudul, Oupicky, David, Das, Suvarthi, Donnelly, Ryan F., Hettie, Kenneth S., Chang, Linda, Gendelman, Howard E., Kevadiya, Bhavesh D.
フォーマット: Artigo
言語:Inglês
出版事項: Published by Elsevier B.V. 2021
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7794055/
https://ncbi.nlm.nih.gov/pubmed/33428995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2021.01.002
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料